Emtricitabine Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / Infections, Coronavirus Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT04334928Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel